The aim of this study was to determine the Human Leukocyte Antigen (HLA) class II ( and ) alleles and haplotype frequency in Rheumatoid Arthritis RA) in the Sudanese population. The frequency of and - alleles and haplotypes were determined in 122 RA patients and 100 controls. HLA alleles were genotyped by the polymerase chain reaction-sequence specific primers (PCR-SSP) method. In RA patients, alleles were high in frequency (9.6% vs 14.2%, = 0.038 and = 0.042, respectively), and dependently on anti-citrullinated protein antibodies (ACPAs) seropositivity ( = 0.044 and = 0.027, respectively). In contrast, the frequency of the allele was significantly low in patients than in controls (11.7% vs 5.0%, = 0.010). Moreover, the allele was strongly associated with RA risk (42.2%, = 2.2x10), whereas, and showed protective effects against RA (23.1% and 42.2%, = 0.024 and = 2.2x10, respectively). Five different HLA haplotypes, ( = 0.00003), ( = 0.00014) ( = 0.027) ( = 0.004), and ( = 3.79x10) were significantly associated with RA risk, while 3 protective haplotypes ( = 0.008), ( = 0.004) ( = 0.02) were identified. This is the first study determining the association between HLA class II alleles and haplotypes and RA risk in our population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324672PMC
http://dx.doi.org/10.3389/fimmu.2023.1178546DOI Listing

Publication Analysis

Top Keywords

hla class
12
class alleles
12
alleles haplotypes
12
human leukocyte
8
leukocyte antigen
8
antigen hla
8
rheumatoid arthritis
8
arthritis sudanese
8
associated risk
8
alleles
6

Similar Publications

The molecular HLA epitope mismatch is an advanced measure for developing donor-specific antibodies (dnDSA) after kidney transplantation. Its relevance in simultaneous pancreas/kidney transplant recipients (SPKTRs) remains unclear. We investigated dnDSA development in 72 SPKTRs and 383 kidney transplant recipients (KTRs) and used the Predicted Indirectly Recognizable HLA-Epitopes (PIRCHE-II) algorithm to calculate the mismatch load of HLA-derived epitopes in total, per HLA-class, and per HLA-locus.

View Article and Find Full Text PDF

[Establishment and Application of Efficient Gene Editing Method for Classical HLA-I Molecules].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

December 2024

Institute of Transfusion Medicine, Blood Center of Zhejiang Province, Hangzhou 310052, Zhejiang Province, China.

Objective: To establish an efficient gene editing method of HLA-I gene to prepare HLA-I universal hematopoietic stem cells.

Methods: The easyedit small guide RNA(sgRNA) was designed according to the sequences of β2 microglobulin gene and synthesized by GenScript company. RNP complexes were formed by NLS-Cas9-NLS nuclease and Easyedit sgRNA according to different molar ratios (1∶1~1∶4).

View Article and Find Full Text PDF

Optimized GVHD Prevention in HLA-Mismatched Unrelated Allogeneic HCT Using a PTCY-Based Approach.

Eur J Haematol

December 2024

Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain.

Although post-transplant cyclophosphamide (PTCY)-based prophylaxis has become a widely adopted strategy for preventing graft-versus-host disease (GVHD) in 9 out of 10 HLA-mismatched unrelated donors (MMUDs), allogeneic hematopoietic cell transplants (allo-HCTs), data on the safety and efficacy of PTCY in this setting remain limited. This single-center study investigates the outcomes of 94 adults with hematological malignancies undergoing MMUD allo-HCT with PTCY and tacrolimus (Tac) (PTCY-Tac) between 2014 and 2023. The median age was 53 years, and 60.

View Article and Find Full Text PDF

Objectives: Platelet transfusion refractoriness (PTR) is a frustrating clinical problem, and primary and persistent (P/P) PTR who experienced persistent PTR since the first transfusion was failed to be well recognized. This study aims to investigate the incidence and risk factors for P/P PTR.

Methods: Patients with hematologic disorders who underwent HLA high-resolution genotyping and donor-specific HLA antibody or panel reactive antibody (PRA) testing between January 2019 and March 2023 were reviewed.

View Article and Find Full Text PDF

: Several significant associations between certain Human Leukocyte Antigen (HLA) alleles and myasthenia gravis (MG) subtypes were established in populations from Western Europe and North America and, to a lesser extent, from China and Japan. However, such data are scarcely available for Eastern Europe. This study aimed to analyze the associations of HLA Class I and II alleles with MG and its serological subtypes (with anti-acetylcholine receptor autoantibodies, RAch+MG, and double-seronegative, dSNMG) in myasthenic patients of Romanian descent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!